Author

Liwen Xu

Stanford MedicineORCID 0000-0001-7986-5928Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Liwen Xu1 paper · Beijing Academy of Agriculture and Forestry Sciences

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Annalisa LattanziiD· 1 shared Daniel P. DeveriD· 1 shared Isabel Ojeda-Pérez· 1 shared Joab CamarenaiD· 1 shared Jose Carlos SegoviaiD· 1 shared José Luis López LorenzoiD· 1 shared Juan Antonio BuereniD· 1 shared Mark A. BehlkeiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Annalisa LattanziORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

GeneticsMolecular Therapy — Methods & Clinical DevelopmentPeer-reviewedMay 13, 2021

Clinically Relevant Gene Editing in Hematopoietic Stem Cells for the Treatment of Pyruvate Kinase Deficiency Hemolytic Anemia

Sara Fañanas-Baquero, Oscar Quintana Bustamante, Daniel P. Dever…·Jose Carlos Segovia

This study uses gene editing in hematopoietic stem cells to treat Pyruvate Kinase Deficiency Hemolytic Anemia, restoring RPK function and ATP levels in erythroid cells.

22 citations

humanexperimental assay

𝕏 PostBluesky